Status:
COMPLETED
Effects of Acute Intake of Caffeinated Beverages in Type 1 Diabetes
Lead Sponsor:
The Royal Bournemouth Hospital
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this pilot study is to determine the impact of caffeine-enhanced energy drinks on blood glucose excursion on heart rate, blood pressure, cardiac output and cognitive performance in patients...
Eligibility Criteria
Inclusion
- Male and female adults aged ≥18 years
- Confirmed diagnosis of Type 1 diabetes of more than one year duration
- Participants who use multiple daily injections of basal and meal-time analogue insulin.
- Ability to perform daily finger stick measurements of blood glucose levels
- Adequate contraceptive control
- Provision of informed consent
Exclusion
- Hypoglycaemia unawareness
- Coronary heart disease
- Cardiac arrhythmia
- Structural heart lesions,
- Autonomic neuropathy
- Psychiatry illness,
- Epilepsy
- Migraine
- Caffeine intolerance
- Unable to provide informed consent
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01805700
Start Date
January 1 2010
End Date
July 1 2011
Last Update
March 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
Bournemouth, Dorset, United Kingdom, BH7 7DW